About AKO
Trading as AKO on the ASX, Akora Resources Ltd sits in Materials and amplia Therapeutics Limited (ATX) is an Australian pharmaceutical business advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. The company has a development focus in fibrotic cancers such as pancreatic and ovarian cancer. FAK also plays a role in chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
All News for AKO
No news articles found for AKO yet.